CLINICAL_TRIALS
trial_result
· 2017-03-07
Clinical Trial Update: Estrogen for Triple Negative Breast Cancer [Phase 2]
Summary
Phase 2 clinical trial investigating estrogen for triple-negative breast cancer was terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Female Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-03-07